SNY logo

Sanofi (SNY) Revenue

Annual revenue:

$47.93B+$2.88B(+6.39%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY annual revenue is $47.93 billion, with the most recent change of +$2.88 billion (+6.39%) on December 1, 2024.
  • During the last 3 years, SNY annual revenue has risen by +$1.58 billion (+3.41%).
  • SNY annual revenue is now -1.94% below its all-time high of $48.88 billion, reached on December 31, 2011.

Performance

SNY Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

Quarterly revenue:

$8.13B-$7.44B(-47.76%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY quarterly revenue is $8.13 billion, with the most recent change of -$7.44 billion (-47.76%) on December 1, 2024.
  • Over the past year, SNY quarterly revenue has stayed the same.
  • SNY quarterly revenue is now -47.76% below its all-time high of $15.57 billion, reached on September 30, 2024.

Performance

SNY Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

TTM revenue:

$48.03B+$192.07M(+0.40%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY TTM revenue is $48.03 billion, with the most recent change of +$192.07 million (+0.40%) on December 1, 2024.
  • Over the past year, SNY TTM revenue has stayed the same.
  • SNY TTM revenue is now -4.17% below its all-time high of $50.13 billion, reached on September 30, 2011.

Performance

SNY TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

SNY Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.4%0.0%0.0%
3 y3 years+3.4%-27.9%+2.5%
5 y5 years+13.8%-27.9%+2.5%

SNY Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+12.1%-47.8%+20.0%at high+12.4%
5 y5-yearat high+13.8%-47.8%+20.0%at high+140.2%
alltimeall time-1.9%+770.0%-47.8%+381.0%-4.2%+2740.2%

Sanofi Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$47.93B(+6.4%)
$8.13B(-47.8%)
$48.03B(+0.4%)
Sep 2024
-
$15.57B(+27.1%)
$47.84B(+3.8%)
Jun 2024
-
$12.25B(+1.5%)
$46.10B(+1.3%)
Mar 2024
-
$12.08B(+52.1%)
$45.49B(+0.9%)
Dec 2023
$45.06B(+5.3%)
$7.94B(-42.6%)
$45.08B(+2.7%)
Sep 2023
-
$13.83B(+18.7%)
$43.92B(+1.4%)
Jun 2023
-
$11.65B(-0.2%)
$43.33B(+0.5%)
Mar 2023
-
$11.67B(+72.2%)
$43.12B(+0.9%)
Dec 2022
$42.78B(-7.7%)
$6.78B(-48.8%)
$42.73B(-10.7%)
Sep 2022
-
$13.23B(+15.7%)
$47.87B(+1.0%)
Jun 2022
-
$11.44B(+1.4%)
$47.40B(+1.2%)
Mar 2022
-
$11.28B(-5.3%)
$46.86B(+1.2%)
Dec 2021
$46.35B(+8.6%)
$11.91B(-6.7%)
$46.29B(+34.7%)
Sep 2021
-
$12.77B(+17.1%)
$34.38B(+59.1%)
Jun 2021
-
$10.90B(+1.8%)
$21.61B(+8.0%)
Mar 2021
-
$10.71B(+15.2%)
$20.00B(-52.0%)
Dec 2020
$42.68B(+1.3%)
-
-
Jun 2020
-
$9.29B(-9.6%)
$41.70B(-1.9%)
Mar 2020
-
$10.28B(-7.3%)
$42.49B(+0.9%)
Dec 2019
$42.13B(+0.0%)
$11.09B(+0.6%)
$42.11B(+1.1%)
Sep 2019
-
$11.03B(+9.3%)
$41.66B(-0.7%)
Jun 2019
-
$10.09B(+1.9%)
$41.96B(-0.1%)
Mar 2019
-
$9.90B(-7.0%)
$41.99B(-0.2%)
Dec 2018
$42.13B(+2.7%)
$10.64B(-6.1%)
$42.08B(+0.1%)
Sep 2018
-
$11.33B(+11.9%)
$42.04B(+0.7%)
Jun 2018
-
$10.13B(+1.4%)
$41.75B(+0.7%)
Mar 2018
-
$9.98B(-5.8%)
$41.45B(+1.2%)
Dec 2017
$41.02B(+6.8%)
$10.60B(-4.0%)
$40.95B(+1.8%)
Sep 2017
-
$11.04B(+12.4%)
$40.24B(+1.7%)
Jun 2017
-
$9.83B(+3.7%)
$39.57B(+1.1%)
Mar 2017
-
$9.48B(-4.1%)
$39.13B(+1.9%)
Dec 2016
$38.40B(-0.7%)
$9.89B(-4.7%)
$38.39B(+6.7%)
Sep 2016
-
$10.37B(+10.5%)
$35.98B(-1.1%)
Jun 2016
-
$9.39B(+7.3%)
$36.36B(-0.8%)
Mar 2016
-
$8.75B(+17.0%)
$36.66B(-1.4%)
Dec 2015
$38.69B(-9.1%)
$7.47B(-30.5%)
$37.19B(-3.5%)
Sep 2015
-
$10.76B(+11.1%)
$38.53B(-2.5%)
Jun 2015
-
$9.68B(+4.4%)
$39.53B(-3.6%)
Mar 2015
-
$9.27B(+5.2%)
$41.02B(-3.7%)
Dec 2014
$42.55B(+2.4%)
$8.82B(-25.0%)
$42.60B(-0.2%)
Sep 2014
-
$11.75B(+5.2%)
$42.67B(+1.1%)
Jun 2014
-
$11.17B(+2.9%)
$42.21B(+1.5%)
Mar 2014
-
$10.86B(+22.1%)
$41.60B(+0.2%)
Dec 2013
$41.56B
$8.89B(-21.3%)
$41.51B(-5.4%)
Sep 2013
-
$11.29B(+6.9%)
$43.86B(-0.6%)
Jun 2013
-
$10.56B(-1.9%)
$44.12B(-2.5%)
DateAnnualQuarterlyTTM
Mar 2013
-
$10.77B(-4.2%)
$45.26B(-2.1%)
Dec 2012
$46.23B(-5.4%)
$11.24B(-2.7%)
$46.21B(-1.7%)
Sep 2012
-
$11.55B(-1.3%)
$47.00B(-2.9%)
Jun 2012
-
$11.71B(-0.1%)
$48.41B(-1.9%)
Mar 2012
-
$11.72B(-2.5%)
$49.34B(+1.0%)
Dec 2011
$48.88B(+8.4%)
$12.02B(-7.3%)
$48.83B(-2.6%)
Sep 2011
-
$12.96B(+2.6%)
$50.13B(+4.8%)
Jun 2011
-
$12.64B(+12.8%)
$47.83B(+1.9%)
Mar 2011
-
$11.21B(-15.9%)
$46.95B(+1.0%)
Dec 2010
$45.11B(+5.2%)
$13.32B(+24.9%)
$46.50B(+4.3%)
Sep 2010
-
$10.67B(-9.3%)
$44.59B(-1.0%)
Jun 2010
-
$11.76B(+9.3%)
$45.04B(+2.6%)
Mar 2010
-
$10.76B(-5.7%)
$43.92B(+2.4%)
Dec 2009
$42.88B(+1.4%)
$11.41B(+2.7%)
$42.89B(+3.9%)
Sep 2009
-
$11.12B(+4.6%)
$41.30B(+1.0%)
Jun 2009
-
$10.63B(+9.2%)
$40.91B(-1.1%)
Mar 2009
-
$9.73B(-0.9%)
$41.38B(-2.1%)
Dec 2008
$42.30B(+5.6%)
$9.82B(-8.5%)
$42.28B(-4.4%)
Sep 2008
-
$10.73B(-3.3%)
$44.23B(+2.6%)
Jun 2008
-
$11.10B(+4.3%)
$43.08B(+2.9%)
Mar 2008
-
$10.64B(-9.6%)
$41.87B(+3.4%)
Dec 2007
$40.04B(+8.1%)
$11.76B(+22.7%)
$40.48B(+5.8%)
Sep 2007
-
$9.59B(-3.0%)
$38.25B(+0.6%)
Jun 2007
-
$9.88B(+6.9%)
$38.04B(+1.4%)
Mar 2007
-
$9.25B(-3.0%)
$37.52B(+1.2%)
Dec 2006
$37.06B(+4.5%)
$9.53B(+1.7%)
$37.08B(+2.2%)
Sep 2006
-
$9.37B(+0.1%)
$36.28B(+0.6%)
Jun 2006
-
$9.36B(+6.3%)
$36.07B(+2.2%)
Mar 2006
-
$8.81B(+0.9%)
$35.28B(+0.2%)
Dec 2005
$35.46B(+81.3%)
$8.73B(-4.8%)
$35.20B(+2.7%)
Sep 2005
-
$9.17B(+6.9%)
$34.29B(+8.3%)
Jun 2005
-
$8.57B(-1.8%)
$31.64B(+22.1%)
Mar 2005
-
$8.73B(+11.7%)
$25.91B(+29.8%)
Dec 2004
$19.55B(+115.0%)
$7.82B(+19.8%)
$19.96B(+40.0%)
Sep 2004
-
$6.52B(+129.9%)
$14.26B(+36.4%)
Jun 2004
-
$2.84B(+2.0%)
$10.45B(+6.3%)
Mar 2004
-
$2.78B(+31.7%)
$9.83B(+7.6%)
Dec 2003
$9.10B(+29.0%)
$2.11B(-22.4%)
$9.14B(+2.5%)
Sep 2003
-
$2.72B(+22.8%)
$8.91B(+11.0%)
Jun 2003
-
$2.22B(+6.1%)
$8.03B(+7.0%)
Mar 2003
-
$2.09B(+10.4%)
$7.51B(+38.5%)
Dec 2002
$7.05B(+21.3%)
$1.89B(+2.8%)
$5.42B(+53.5%)
Sep 2002
-
$1.84B(+8.8%)
$3.53B(+108.8%)
Jun 2002
-
$1.69B
$1.69B
Dec 2001
$5.81B(+5.5%)
-
-
Dec 2000
$5.51B(-3.3%)
-
-
Dec 1999
$5.70B
-
-

FAQ

  • What is Sanofi annual revenue?
  • What is the all time high annual revenue for Sanofi?
  • What is Sanofi annual revenue year-on-year change?
  • What is Sanofi quarterly revenue?
  • What is the all time high quarterly revenue for Sanofi?
  • What is Sanofi quarterly revenue year-on-year change?
  • What is Sanofi TTM revenue?
  • What is the all time high TTM revenue for Sanofi?
  • What is Sanofi TTM revenue year-on-year change?

What is Sanofi annual revenue?

The current annual revenue of SNY is $47.93B

What is the all time high annual revenue for Sanofi?

Sanofi all-time high annual revenue is $48.88B

What is Sanofi annual revenue year-on-year change?

Over the past year, SNY annual revenue has changed by +$2.88B (+6.39%)

What is Sanofi quarterly revenue?

The current quarterly revenue of SNY is $8.13B

What is the all time high quarterly revenue for Sanofi?

Sanofi all-time high quarterly revenue is $15.57B

What is Sanofi quarterly revenue year-on-year change?

Over the past year, SNY quarterly revenue has changed by $0.00 (0.00%)

What is Sanofi TTM revenue?

The current TTM revenue of SNY is $48.03B

What is the all time high TTM revenue for Sanofi?

Sanofi all-time high TTM revenue is $50.13B

What is Sanofi TTM revenue year-on-year change?

Over the past year, SNY TTM revenue has changed by $0.00 (0.00%)
On this page